Managing behavior in mentally retarded residential populations.
Deutsch
S I
SI
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000374:Aggression / Q000187:drug effects; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D006801:Humans; D007326:Institutionalization; D008607:Intellectual Disability / Q000188:drug therapy*; D008094:Lithium / Q000627:therapeutic use; D011595:Psychomotor Agitation / Q000188:drug therapy; D013239:Stereotyped Behavior / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents; D002220:Carbamazepine; D008094:Lithium